Preoperative detection of ovarian cancer by colour Doppler ultrasonography and CA125

被引:0
|
作者
Hossain, F. [1 ,2 ,3 ]
Khan, N. [1 ,2 ,3 ]
Hussain, R. [1 ,2 ,3 ]
机构
[1] Bangabandhu Sheikh Mujib Med Univ, Dhaka, Bangladesh
[2] Inst Publ Hlth, Dhaka, Bangladesh
[3] Inst Nucl Med, Dhaka, Bangladesh
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:160 / 160
页数:1
相关论文
共 50 条
  • [21] Personalizing CA125 Levels for Ovarian Cancer Screening
    Dorigo, Oliver
    Berek, Jonathan S.
    CANCER PREVENTION RESEARCH, 2011, 4 (09) : 1356 - 1359
  • [22] CA125 GLYCOFORM ASSAY IMPROVES THE PERFORMANCE OF CONVENTIONAL CA125 IN THE DIAGNOSTICS OF EPITHELIAL OVARIAN CANCER
    Salminen, L.
    Gidwani, K.
    Rolfsen, A. L.
    Nadeem, N.
    Bolstad, N.
    Dorum, A.
    Grenman, S.
    Hietanen, S.
    Perheentupa, A.
    Poutanen, M.
    Carpen, O.
    Lamminmaki, U.
    Pettersson, K.
    Hynninen, J.
    Huhtinen, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 825 - 825
  • [23] Ovarian hemangioma with elevated CA125 and ascites mimicking ovarian cancer
    Erdemoglu, E
    Kamaci, M
    Özen, S
    Sahin, HG
    Kolusari, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2006, 27 (02) : 195 - 196
  • [24] Evaluation of osteopontin and CA125 in detection of epithelial ovarian carcinoma
    Milivojevic, M.
    Boskovic, V.
    Atanackovic, J.
    Milicevic, S.
    Razic, S.
    Kotlica, B. Kastratovic
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (01) : 83 - 85
  • [25] Proteomic markers increase CA125 sensitivity for early detection of epithelial ovarian cancer
    Wright, J. D.
    Neugut, A. I.
    Doan, T.
    McBride, R.
    Jacobson, J. S.
    Hershman, D.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S36 - S36
  • [26] Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
    Barr, Chloe E.
    Njoku, Kelechi
    Owens, Gemma L.
    Crosbie, Emma J.
    CANCERS, 2023, 15 (04)
  • [27] Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer
    Arits, A. H. M. M.
    Stoot, J. E. G. M.
    Botterweck, A. A. M.
    Roumen, F. J. M. E.
    Voogd, A. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (04) : 621 - 628
  • [28] Nadir CA125 concentration as a prognostic indicator in ovarian cancer
    Baron, AT
    Maihle, N
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 288 - 289
  • [29] CA125 response to bevacizumab in recurrent ovarian cancer.
    O'Cearbhaill, R. E.
    Zhou, Q.
    Iasonos, A.
    Diaz, J. P.
    Tew, W. P.
    Hensley, M. L.
    O'Flaherty, C.
    Aghajanian, C.
    Spriggs, D. R.
    Sabbatini, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Nadir CA125 concentration as a prognostic indicator in ovarian cancer
    Andre T Baron
    Nita Maihle
    Nature Clinical Practice Oncology, 2005, 2 : 288 - 289